Venturi Wealth Management LLC Grows Stake in Cigna Group $CI

Venturi Wealth Management LLC grew its holdings in Cigna Group (NYSE:CI) by 5.3% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 896 shares of the health services provider’s stock after buying an additional 45 shares during the quarter. Venturi Wealth Management LLC’s holdings in Cigna Group were worth $296,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Valeo Financial Advisors LLC lifted its stake in shares of Cigna Group by 86,071.1% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after purchasing an additional 3,471,249 shares during the period. Nuveen LLC purchased a new position in shares of Cigna Group in the 1st quarter valued at approximately $727,905,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Cigna Group by 10.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after purchasing an additional 1,094,327 shares during the period. GQG Partners LLC lifted its stake in shares of Cigna Group by 21.5% in the 1st quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the period. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Cigna Group by 38.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,649,837 shares of the health services provider’s stock valued at $542,796,000 after purchasing an additional 457,052 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 1.7%

Cigna Group stock opened at $301.00 on Friday. The firm has a market cap of $80.35 billion, a price-to-earnings ratio of 16.43, a PEG ratio of 0.90 and a beta of 0.45. The stock has a fifty day simple moving average of $294.68 and a two-hundred day simple moving average of $309.31. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.88. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to analyst estimates of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the company earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were issued a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. Cigna Group’s dividend payout ratio (DPR) is presently 32.97%.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at approximately $15,354,600. The trade was a 9.49% decrease in their position. The disclosure for this sale can be found here. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Royal Bank Of Canada restated an “outperform” rating and issued a $371.00 target price on shares of Cigna Group in a research note on Thursday, June 26th. Truist Financial set a $375.00 target price on Cigna Group in a research note on Tuesday, September 2nd. Wells Fargo & Company raised their price objective on Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft set a $415.00 price objective on Cigna Group and gave the company a “buy” rating in a research report on Tuesday, August 5th. Finally, TD Cowen raised Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $372.69.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.